ALAN CRANE

Profile

First Name

: ALAN

Middle Name

:

Last Name

: CRANE

Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-17 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-12-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-02-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-07 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-07-28 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-20 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-07-28 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-03-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-11-06 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-03-19 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-03-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-02 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-10-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-26 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-11-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-13